Would like to see a buyout here. Why. The average drug takes 10 to 15 years to make and a cost of 2.6 billion. We are at stage 3 with orphan drug status. That is many millions already invested in a hugely promising cancer drug. Definitely eyes on this patent. No way it just expired and goes obsolete. Someone partners or buys . The company needs a cash injection to restart operations , but would likely rather take the money and run if the price is right. That’s my guess anyway
News 
Market Data 
Discover 
